Importantly, the company is actively pursuing a sale of its Life Sciences & Healthcare segment, with Morgan Stanley retained as advisor. A successful divestiture could accelerate deleveraging and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results